- Home
- GOVX
GOVX
GeoVax Labs Inc.
as 03-28-2025 4:00pm EST
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | SMYRNA |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $14.20 | AVG Volume (30 days): | 799.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.82 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.09 - $11.18 | Next Earning Date: | 03-27-2025 |
| Revenue: | $3,954,576 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 256.45% | Revenue Growth (next year): | -54.41% |
Latest GeoVax Labs Inc. News
GOVX Breaking Stock News: Dive into GOVX Ticker-Specific Updates for Smart Investing
GuruFocus.com
3 days ago
Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...
NewMediaWire
4 days ago
GeoVax Reports 2024 Year-End Financial Results and Provides Business Update
GlobeNewswire
6 days ago
Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now
NewMediaWire
7 days ago
GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
NewMediaWire
14 days ago
GeoVax to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025
NewMediaWire
19 days ago
GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK
NewMediaWire
20 days ago
GeoVax to Present at the 37th Annual Roth Conference
NewMediaWire
a month ago
Registration is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event MPOX 2025: Navigating the Global Public Health Emergency Featuring GeoVax CEO On March 6, 2025
Compare GOVX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GOVX GeoVax Labs Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.